EP3247437A1 - Respirator having improved synchronicity during the transition from expiratory to inspiratory operation - Google Patents
Respirator having improved synchronicity during the transition from expiratory to inspiratory operationInfo
- Publication number
- EP3247437A1 EP3247437A1 EP17716248.4A EP17716248A EP3247437A1 EP 3247437 A1 EP3247437 A1 EP 3247437A1 EP 17716248 A EP17716248 A EP 17716248A EP 3247437 A1 EP3247437 A1 EP 3247437A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- expiratory
- ventilator
- time constant
- flow
- inspiratory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003434 inspiratory effect Effects 0.000 title claims abstract description 62
- 230000007704 transition Effects 0.000 title claims abstract description 24
- 230000008859 change Effects 0.000 claims abstract description 90
- 230000029058 respiratory gaseous exchange Effects 0.000 claims abstract description 79
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 8
- 230000000241 respiratory effect Effects 0.000 claims description 55
- 238000009423 ventilation Methods 0.000 claims description 24
- 230000004907 flux Effects 0.000 claims description 14
- 238000012935 Averaging Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 2
- 230000001052 transient effect Effects 0.000 claims 1
- 230000003319 supportive effect Effects 0.000 abstract 1
- 239000007789 gas Substances 0.000 description 72
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 27
- 210000002345 respiratory system Anatomy 0.000 description 27
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 21
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 21
- 210000004072 lung Anatomy 0.000 description 18
- 238000000034 method Methods 0.000 description 12
- 230000001351 cycling effect Effects 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 230000002123 temporal effect Effects 0.000 description 8
- 230000006399 behavior Effects 0.000 description 6
- 230000001575 pathological effect Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000000414 obstructive effect Effects 0.000 description 5
- 230000003750 conditioning effect Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 3
- 238000001595 flow curve Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 229940124446 critical care medicine Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 210000003019 respiratory muscle Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/021—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
- A61M16/022—Control means therefor
- A61M16/024—Control means therefor including calculation means, e.g. using a processor
- A61M16/026—Control means therefor including calculation means, e.g. using a processor specially adapted for predicting, e.g. for determining an information representative of a flow limitation during a ventilation cycle by using a root square technique or a regression analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/104—Preparation of respiratory gases or vapours specially adapted for anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/20—Valves specially adapted to medical respiratory devices
- A61M16/208—Non-controlled one-way valves, e.g. exhalation, check, pop-off non-rebreathing valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/087—Measuring breath flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/01—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes specially adapted for anaesthetising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
- A61M16/16—Devices to humidify the respiration air
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/20—Valves specially adapted to medical respiratory devices
- A61M16/201—Controlled valves
- A61M16/202—Controlled valves electrically actuated
- A61M16/203—Proportional
- A61M16/204—Proportional used for inhalation control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/20—Valves specially adapted to medical respiratory devices
- A61M16/201—Controlled valves
- A61M16/202—Controlled valves electrically actuated
- A61M16/203—Proportional
- A61M16/205—Proportional used for exhalation control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/0015—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
- A61M2016/0018—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/0027—Accessories therefor, e.g. sensors, vibrators, negative pressure pressure meter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/003—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
- A61M2016/0033—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
- A61M2016/0036—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical in the breathing tube and used in both inspiratory and expiratory phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/003—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
- A61M2016/0033—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
- A61M2016/0042—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical in the expiratory circuit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
- A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/40—Respiratory characteristics
- A61M2230/42—Rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/40—Respiratory characteristics
- A61M2230/46—Resistance or compliance of the lungs
Definitions
- the present invention relates to a ventilator for at least assisting respiration of healthy animals breathing in the healthy state, wherein the ventilator comprises:
- connection formation for connection to a breathing gas supply
- inspiratory inspiratory respiratory gas fresh inspiratory breathing gas from the junction formation to a patient interface and metabolized in expiratory mode. expiratory breathing gas away from the patient interface leading respiratory gas conduit,
- a pressure variation arrangement for varying the pressure of breathing gas in the breathing gas conduit
- a flow sensor configured and arranged to provide a flow signal representative of a flow of breathing gas at least from expiratory breathing gas in the breathing gas conduit;
- a controller controlling the operation of the ventilator configured to trigger a transition from expiratory to inspiratory operation of the ventilator when an increase in the slope of a flow waveform representing successive flow signals exceeds a slope change threshold.
- Such a generic ventilator is known from EP 0 521 314 A1.
- This document teaches switching a respirator between an expiratory phase and an inspiratory phase when the respiratory flow curve determined during the ventilation phase shows a significant increase in its steepness. Whether or not there is such a significant increase is determined based on a comparison of an increase in steepness with a predetermined slope change threshold.
- This lesson represents an improvement
- Another trigger criterion is the basic level crossing, such as a zero crossing or a passage through a non-zero base level, the respiratory flow curve, ie the temporal flow waveform , This trigger criterion is known for example from US 3,834,382.
- the disadvantage of this criterion is that it essentially works satisfactorily only in patients with a healthy respiratory system, whereas during the artificial respiration of chronic obstructive patients (COPD patients) unpleasant asynchronous can occur for the patient when the patient during spontaneous breathing spontaneous breathing shows.
- COPD patients chronic obstructive patients
- the trigger criterion of a base level crossing of the flow signal is sensitive to leakage-related effects that may occur in artificial respiration, for example because a respiratory mask, as a potential patient interface, does not completely terminate with the nose and mouth of the patient being ventilated. Other causes can cause leakage currents and thus leakage-induced effects during artificial respiration.
- DE 44 32 219 C1 teaches to increase a breathing gas flow trigger threshold for a transition from expiratory to inspiratory operation by an additional amount that is formed by the ratio between the averaged respiratory pressure during the Inspiration and the sum of the averaged breath pressures during inspiration and expiration, multiplied by the difference in the averaged values of the respiratory flows during inspiration and during expiration.
- ETS is termed the "Expiratory Trigger Sensitivity", which is a percentage of the maximum respiratory gas flow occurring during an inspiratory procedure that serves as the cycling threshold, when the inspiratory gas flow has dropped to the predetermined cycling threshold during the inspiratory phase In the case of healthy patients, the ETS-based cycling threshold is often about 25% of the maximum respiratory gas flow during the inspiratory phase.
- the predetermined slope change threshold used in this case is always a compromise that is common to all patients should be applicable and therefore may lead in individual cases to asynchronities in the ventilation because the patient to be respirated in each case only partially applies to the case underlying the predetermined slope change threshold.
- a generic respirator in which the control device is further configured to determine the slope change threshold value as a function of an expiratory time constant of the respective patient to be ventilated and the transition from expiratory operation to inspiratory operation of the patient Ventilator then to trig when the increase in the slope of the flux waveform exceeds the slope change threshold determined according to the expiratory time constant.
- triggering in the present application refers only to the initiation of a transition from expiratory to inspiratory operation of the ventilator, but to trigger a transition in the opposite direction from inspiratory to expiratory, the term “cycling "used.
- COPD patients which have an above-average expiratory time constant compared to patients with healthy respiratory systems
- ARDS patients whose expiratory time constant compared to patients with healthy respiratory systems above average is short.
- COPD which is commonly referred to as “asthma” or “smoker's lung”
- ARDS patients have a restorative respiratory system, commonly referred to as a "hard” lung, where respiration is often jerky, which during one expiratory phase can lead to one or more discontinuities in the flow of breathing gas flow in the form of kinks Amount changes in the slope of the flow signal, which can trigger a car triggers at unfavorably selected slope change threshold.
- the present invention also helps to ventilate ARDS patients with the inventively improved ventilator with improved synchrony. Because of the relationship described, it is advantageous to ventilate ARDS patients whose expiratory time constant is smaller than those of patients with a healthy respiratory system with a magnitude-increasing steepness change threshold in order to control ARDS-typical discontinuities in the flow signal course during an expiratory phase through the slope. Not to detect change threshold and correctly take only a magnitude larger change in the slope of the flow waveform at the end of the expiratory phase as a trigger signal, if in fact should take place in accordance with the patient behavior, a transition from expiratory to inspiratory operation. Similarly, COPD patients whose expiratory time constant is greater than those of healthy respiratory system patients may be ventilated at a slope change threshold that is lower in magnitude than that of ARDS patients and lower than that of patients with a healthy respiratory system.
- the controller is preferably configured to reduce the magnitude of the slope change threshold as the expiratory time constant increases, and vice versa.
- control device is preferably designed to check only those changes in the steepness of the flux waveform to the presence of exceeding the steepness change threshold value by which the slope of the flux waveform increases, that is, the flux waveform progressively increases.
- the slope change threshold is then preferably a slope increase threshold to apply in rising flux waveform sections, but not in descending ones.
- the trigger criterion discussed in the present application is not the only trigger criterion according to which the control device can change or change the operation of the ventilation device from expiratory to inspiratory.
- the control device preferably has a plurality, for example more than 25, trigger criteria, each of which, in the event of its presence, causes the control device to switch the operation of the ventilation device from expiratory to inspiratory.
- the control device interacts with an input device, such as a keyboard and the like, by which the input of an expiratory time constant applicable to the respective patient to be ventilated is possible.
- an input device such as a keyboard and the like
- the control device is preferably designed to determine the expiratory time constant in a respective ventilation application.
- the flow sensor preferably detects the respiratory gas flow as a volumetric flow. An additional or alternative detection as a mass flow is also possible.
- the control device being designed to detect the expiratory time constant in a spectacular manner.
- control device may be designed to calculate the expiratory time constant in accordance with the ratio between the volume exhaled during an expiratory procedure and the maximum expiratory volume flow occurring, preferably iteratively numerically, and / or according to the resistance occurring during a respiratory stroke Determine compliance. Determining the resistance and the compliance separately and calculating the expiratory time constant from multiplication is possible, but less preferred than the time constant from the ratio of exhaled volume and thereby calculated maximum expiratory flow rate.
- iterative numerical calculation methods which converge to a true value after only a few iteration steps, which only differs to a negligible extent from the actual time constant for the respective ventilation case.
- flow waveform is not intended to be construed to record and provide the full time course of the flux signal provided by the flow sensor It is sufficient to obtain the advantages of the present invention if the flow waveform is present for such a long period of time Also, the term “flow waveform” should not be misunderstood to the effect that a continuous course is required for determining a change in the slope of it.
- a sequence of chronologically successive discrete flow signal values also represents a flow signal course in the sense of the present application. For example, three flow signal values ascertained chronologically one after the other suffice to determine and evaluate a change in the steepness of this short flow signal course.
- a slope of the flow signal course between these two interpolation points can be determined and also between the second and third flow signal value, again by a difference quotient.
- the slopes thus determined, once between the first and second flow signal values and once again between the second and third flow signal values, can be compared with one another, for example by subtraction, the difference value, which represents a measure of the change in the slope or steepness of the flow signal course, with the slope.
- Change threshold of the flow waveform can be compared. Depending on the outcome of such a comparison with the slope change threshold, then triggering may or may not be initiated.
- flow signal profile can be approximated at least in sections by a function, which approximation function can be derived twice over time.
- the second derivative of a function is known to be a measure of the change in the slope of a function or a value curve.
- the relationship may also affect its sign beyond the magnitude of the slope change threshold.
- the relationship can be stored in the form of a tabular or graphical map.
- a functional relationship between the magnitude of the slope change threshold value and the expiratory time constant or a functional relationship between a change value of the slope change threshold value and the expiratory time constant is preferably stored in the data memory, depending on whether the slope change threshold absolute value is determined or only one on The change amount to be applied to the previously used steepness change threshold is to be determined, that is, whether the change in the slope change threshold value should be absolute or incremental. Both are possible in principle.
- the control device is then preferably designed to determine an applicable slope change threshold based on the expiratory time constant on the basis of the functional relationship.
- the ventilator preferably has a data memory which can be written by the control device and in which flow signal values provided by the flow sensor can be stored in order to determine from the values a temporal flow signal course. This may be the above-mentioned data store.
- the control device is designed to smooth the flow signal provided by the flow sensor, for example by low-pass filtering or by smooth averaging.
- the moving averaging can take into account the last five to six flow signal values, optionally weighted.
- a smoothing of the temporal flux waveform is particularly advantageous if the change in the slope of the flow waveform should be made by differentiating an approximated approximately to the flow waveform approximated proximity function, since an approximation function for a smooth waveform with low error can be determined.
- the determination of the expiratory time constant preferably takes place on the basis of the smoothed flow signal course.
- the control device is adapted to the transition from expiratory operation to inspiratory operation of the ventilator not before a predetermined period of time after a predetermined characteristic event, such as a start of the expiratory operation or a base level crossing of the flow signal to trigger.
- a predetermined characteristic event such as a start of the expiratory operation or a base level crossing of the flow signal to trigger.
- the base level crossing of the flow signal may be a pass through a zero level or a non-zero base level.
- an inspiratory valve of the ventilator is usually closed and an expiratory valve opened, allowing the patient to reverse the direction of the respiratory gas flow.
- the flux signal thereby changes the sign, that is, initially falls sharply in magnitude, and then rises sharply in magnitude with the opposite sign. Starting from the maximum respiratory gas flow then occurring, the flow signal drops again in magnitude as the expiration progresses. Therefore, as a rule, at the beginning of an expiratory phase there is a change in the steepness of the flow signal course, which, however, is not intended to trigger a transition from expiratory to inspiratory operation. This is prevented with the previously described measure.
- the predetermined period of time within which no transition should be triggered as of the occurrence of the characteristic event in accordance with the expiratory time constant, since in COPD patients the expiratory phase lasts longer than in patients with a healthy respiratory system and In ARDS patients, the expiratory phase is shorter than in patients with a healthy respiratory system.
- the predetermined period of time may be shorter in ARDS patients than in patients with a healthy respiratory system and in turn shorter than that of COPD patients.
- the predetermined period of time can therefore be selected, for example, proportionally to the expiratory time constant.
- FIG. 1 shows a schematic representation of an artificial one according to the invention
- FIG. 2 a shows an exemplary time profile of a flow signal of a COPD patient
- FIG. 2b is an exemplary graphical representation of increases in the slope of the flow waveform with an applicable steepness change threshold occurring in the time-flux waveform of FIG. 2a for triggering an inspiratory process;
- FIG. 3 a shows an exemplary time profile of a flow signal of an ARDS patient
- FIG. 3b is an exemplary graphical representation of increases in the slope of the flux waveform with an applicable transconductance change threshold occurring in the time waveform of FIG. 3a for triggering an inspiratory process.
- FIG. 1 an embodiment of a ventilation device according to the invention is designated generally by 10.
- the respiratory device 10 is used in the illustrated example for the artificial respiration of a human patient 12 in PSV mode.
- the respiratory device 10 has a housing 14, in which - a pressure change arrangement 16 and a control device 18 can be accommodated, which is not visible from outside because of the opaque housing material.
- the pressure variation assembly 16 is constructed in a manner known per se and may include a pump, a compressor, a blower, a pressure vessel, a reducing valve, and the like.
- the respiratory device 10 in a known manner, an inspiratory valve 20 and an expiratory valve 22.
- the control device 18 is usually realized as a computer or microprocessor. It comprises a memory device, not shown in FIG. 1, in order to be able to store and, if necessary, call up data necessary for the operation of the respiration device 10.
- the storage device may be in network operation Also located outside of the housing 14 and be connected by a data transmission connection to the controller 18.
- the data transmission connection may be formed by a cable or a radio link.
- the memory device is preferably integrated in the control device 18 or at least accommodated in the same housing 14 as the latter.
- the respiration device 10 can have a data input 24, which is represented by a keyboard in the example shown in FIG.
- the keypad is not the only data input to the controller 18.
- the controller 18 may receive data through various data inputs, such as via a network line, a radio link, or via sensor ports 26, discussed in greater detail below ,
- the respiratory device 10 can have an output device 28, in the example illustrated a screen.
- the patient 12 is connected to the respiratory device 10, more precisely to the pressure change arrangement 16 in the housing 14, via a breathing gas line arrangement 30.
- the patient 12 is intubated for this purpose.
- the tube 31 forms a patient interface of the ventilator 10.
- the patient interface may include a mask covering the nose and mouth.
- the respirator 10 also has a connection formation (not shown in FIG. 1) for connection to a breathing gas supply.
- this connection formation can be an intake pipe, through which ambient air - if desired with the interposition of a filter - can be sucked into the breathing gas line arrangement 30 from the immediate surroundings of the ventilator 10.
- the connection formation can also be a Strömungs effetkupp- ment, by means of which the ventilator with a gas supply - be it air or oxygen - connectable.
- the gas supply can be, for example, a gas container or a collective supply, as it is installed in clinics as part of the building services.
- the breathing gas line arrangement 30 has an inspiratory tube 32, via which fresh breathing gas can be conducted from the pressure change arrangement 16 into the lungs of the patient 12.
- the inspiration tube 32 can be interrupted and have a first inspiration tube 34 and a second inspiration tube 36, between which a conditioning device 38 for targeted humidification and possibly also temperature control of the patient 12 supplied fresh breathing gas can be provided.
- the conditioning device 38 can be connected to an external fluid reservoir 40, via which water for humidification or else a medicament, for example for inhibiting inflammation or for widening the respiratory tract, can be supplied to the conditioning device 38.
- volatile anesthetics can be delivered in a controlled manner to the patient 12 via the ventilation device 10.
- the conditioning device 38 ensures that the fresh breathing gas is supplied to the patient 12 with a predetermined moisture content, optionally with the addition of a medicament aerosol and at a predetermined temperature.
- the breathing gas line arrangement 30 also has an expiratory tube 42, via which the metabolite is evacuated. Breathing gas is blown out of the lungs of the patient 12 into the atmosphere.
- the inspiratory tube 32 is coupled to the inspiration valve 20, the expiratory tube 42 to the expiratory valve 22. Only one of the two valves is opened at the same time for the passage of a gas flow.
- the actuation control of the valves 20 and 22 is likewise effected by the control device 18.
- the exhalation valve 22 is initially closed for the duration of the inspiration phase, and the inspiration valve 20 is opened, so that fresh breathing gas can be conducted from the housing 14 to the patient 12.
- a flow of the fresh respiratory gas is effected by targeted pressure increase of the respiratory gas by the pressure change arrangement 16.
- the fresh respiratory gas flows into the lungs of the patient 12 and expands there the body area near the lungs, ie in particular the thorax, against the individual elasticity of the body parts close to the lungs. As a result, the gas pressure inside the lung of the patient 12 also increases.
- the inspiration valve 20 is closed and the expiratory valve 22 is opened. It begins the expiratory phase. Due to the increased gas pressure of the respiratory gas located in the lungs of the patient 12 until the end of the inspiration phase, this gas flows into the atmosphere after the expiratory valve 22 has been opened, the gas pressure in the lungs of the patient 12 decreasing as the flow duration progresses. If, for example, the gas pressure in the lungs 12 reaches a positive end-expiratory pressure, ie a slightly higher pressure than the atmospheric pressure, set on the respiration device 10, the expiratory phase is terminated when the expiration valve 22 closes and another ventilation cycle follows.
- a positive end-expiratory pressure ie a slightly higher pressure than the atmospheric pressure
- the patient 12 is supplied with the so-called respiratory tidal volume, ie the respiratory gas volume per breath.
- the respiratory device 10, in particular the control device 18, is designed to repeat respiratory operating parameters that characterize the ventilation mode of the respiratory device 10 during the ventilator operation to update or to determine to ensure that the ventilator is tuned as optimally as possible to each patient to be respirated 12 at any time.
- the determination of one or more respiratory operating parameters with the respiration frequency is particularly advantageous, so that current and thus optimally adapted to the patient 12 ventilation operating parameters can be provided for each ventilation cycle.
- the respirator 10 is communicatively coupled to at least one of a flow sensor 44, preferably further sensors, such as a pressure sensor for measuring respiratory gas pressure in the breathing gas conduit assembly 30.
- the flow sensor 44 detects the respiratory gas flow prevailing in the breathing gas line arrangement 30 and outputs a signal representing the respiratory gas flow or the respiratory gas flow.
- the flow sensor 44 is preferably coupled to the data inputs 26 of the control device 18 by means of a sensor line arrangement 46.
- the sensor lead 46 may or may not include electrical signal transmission lines. It can also have hose lines which transmit the gas pressure prevailing in the direction of flow on both sides of the flow sensor 44 to the data inputs 26, where these are quantified by pressure sensors (not shown in FIG. 1).
- the respiration device 10 can be accommodated as a mobile respiration device 10 on a rollable frame 48.
- the flow sensor 44 is preferably located in a portion of the breathing gas conduit assembly 30 in which it can sense both the inspiratory flow and the expiratory flow.
- at least one further flow sensor may be provided in the inspiration hose 32 and / or in the expiration hose 42 and / or in the housing 14.
- FIG. 2 a shows, by way of example and roughly schematically, a temporal flow signal course 50, as is the case when the patient 12 of FIG. 1 is a COPD patient.
- the inspiratory process begins at time to, at which the controller 18 initiates the inspiratory process described above and increases the pressure in the inspiratory line 32 to a preset inspiratory pressure.
- the respiratory gas flow increases rapidly, for example as a volumetric flow in volume per unit of time, and then gradually decreases in magnitude as the lung is filled with fresh respiratory gas.
- the respiratory gas flow toward the patient 12 or into the patient 12 is, as agreed, subject to a positive sign.
- the magnitude of the slope or the steepness of the flow signal course 50 between the support points 52 and 54 changes in comparison to the support points which proceed in the support point 52.
- the slope is increasing.
- the slope of the flux waveform 50 again changes between the bases 54 and 56. The slope increases again.
- the increase in the steepness is plotted over the time axis t, correlated with the time axis t of FIG. 2a.
- the change in the steepness of the flux signal course 50 from the interpolation point 52 to the interpolation point 54 is plotted lower than the change in the slope of the profile compared to the previous course of the curve
- the changes in the steepness are respectively assigned to the temporally later interpolation points of a pair of interpolation points used for calculating the steepness, ie the interpolation points 54 and 56.
- the change value, in particular the increase value, the steepness of the flux waveform 50 in the region of the interpolation points 52 and 54, as compared with a preceding history section, is therefore designated 54s and the change value, in particular the increase value, of the wave signal course in the area of the support point pairs 54 and 56 relative to the section between the support point pair 50 and 52 is designated by 56s.
- a slope change threshold value 58 is entered in FIG. 2b, which is used as a trigger criterion for triggering a transition from the expiratory operation to the inspiratory operation of the ventilation device 10.
- the slope change threshold 58 is appropriately selected in the example of FIG. 2b for COPD patients such that the change value 54s at which the patient is still in the expiratory phase and has not made his own effort for inspiration is below the slope change threshold 58 is.
- the modifier 56s returns to a typical COPD patient value when exercising its own inspiratory effort, such that this value exceeds the transconductance threshold 58, thus causing the controller 18 to switch the ventilator 10 from an expiratory mode to an inspiratory mode.
- a temporal threshold 60 is stored in the control device 18, from which only a change in the slope of the temporal flow signal curve 50 to provide a Trigger signal is observed.
- the temporal threshold 60 may be, for example, a predetermined period of time from the closing of the inspiratory valve 20 or from the opening of the expiratory valve 22.
- FIGS. 3 a and 3 b show a representation of a flow signal course 150 corresponding to FIGS. 2 a and 2 b for an ARDS patient.
- ARDS patients have a so-called restruc- tive respiratory system whose compliance is very low. The respiratory system is less elastic than in respiratory healthy patients. In COPD patients, on the other hand, the resistance of the respiratory system to respiratory healthy patients is increased. Due to the decreased compliance of the respiratory system of ARDS patients, the introduction of fresh respiratory gas into the lungs of the patient requires increased work against the relatively inelastic lung and also inelastic respiratory tract.
- the flow waveform 150 is therefore generally steeper than in respiratory healthy patients and especially steeper than COPD patients. The maximum amounts of the river reached are also larger.
- FIGS. 2 a and 2 b Same and functionally identical details as in FIGS. 2 a and 2 b are denoted by the same reference symbols in FIGS. 3 a and 3 b, but increased by the number 100.
- the expiratory flow of breathing gas at the beginning of the expiratory phase reaches a value higher than in the case of a COPD patient, which is due to the obstructive breathing of the COPD patient as well as to the low compliance of the ARDS patient.
- the expiratory flow of respiratory gas in the ARDS patient falls faster in accordance with FIG. 3a than in the COPD patient.
- the slope of the flow waveform in the ARDS patient usually changes several times during the expiratory phase.
- the slope change threshold 158 for ARDS patients is therefore advantageously chosen larger than that for COPD patients.
- a corresponding slope change threshold for respiratory healthy patients could be between thresholds 58 and 158.
- the PSV mode assistantly ventilated ARDS patient begins to aspirate breathing gas, which leads to a considerable increase in the steepness of the flow waveform 150.
- the course section between the support points 154 and 156 is significantly steeper or has a significantly greater slope than the immediately preceding course section between the support points 152 and 154. Due to the own inspiratory effort of at least occasionally spontaneously respiring during respiration ARDS patient finds this increase in the flow waveform right down to a positive flow signal.
- the associated change value 156s is shown in FIG. 3b. He exceeds the limit for ARDS Patients defined slope change threshold 158 and thus triggers a changeover from expiratory to inspiratory operation of the ventilator 10.
- a data memory of the ventilator 10 may include, in the form of a map, a table, a stored function or approximation function, and the like, a relationship between the slope change threshold to be applied in a ventilator case and an expiratory time constant characterizing the condition of the patient 12's respiratory system.
- control device 18 can then use the stored relationship to query the steepness change threshold value to be used for the patient 12 currently to be ventilated or to determine it by arithmetic operations.
- the expiratory time constant of the patient 12 currently being ventilated may be manually entered by medical personnel into the ventilator 10, if known, such as to have at least an initial value for the slope change threshold.
- the control device 18 is designed to determine the expiratory time constant of the respective patient 12 to be ventilated on the basis of the sensor information that is accessible to it.
- the expiratory time constant can be performed solely on the basis of the information received from the flow sensor 44.
- the expiratory time constant can be determined on the basis of the respiratory gas volume exhaled during an expiratory phase and the maximum respiratory gas flow that has occurred during the same expiratory phase. Further possible investigation methods for determining the expiratory time constant have already been mentioned above in the introduction to the description.
- the ventilator 10 is able to determine the condition of the respiratory system of the patient 12 and based on the determined state of the respiratory system adapt the slope-dependent trigger criterion for a changeover of the ventilator 10 from expiratory to inspiratory operation to the respective patient to be ventilated.
Landscapes
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102016206442.8A DE102016206442A1 (en) | 2016-04-15 | 2016-04-15 | Ventilator with improved synchrony in the transition from expiratory to inspiratory operation |
PCT/EP2017/058577 WO2017178440A1 (en) | 2016-04-15 | 2017-04-10 | Respirator having improved synchronicity during the transition from expiratory to inspiratory operation |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3247437A1 true EP3247437A1 (en) | 2017-11-29 |
EP3247437B1 EP3247437B1 (en) | 2018-10-31 |
Family
ID=58503650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17716248.4A Active EP3247437B1 (en) | 2016-04-15 | 2017-04-10 | Respirator having improved synchronicity during the transition from expiratory to inspiratory operation |
Country Status (7)
Country | Link |
---|---|
US (1) | US20200215283A9 (en) |
EP (1) | EP3247437B1 (en) |
JP (1) | JP2019511301A (en) |
CN (1) | CN109069780A (en) |
AU (1) | AU2017251164A1 (en) |
DE (1) | DE102016206442A1 (en) |
WO (1) | WO2017178440A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102017006655A1 (en) * | 2017-07-13 | 2019-01-17 | GRÜNDLER GmbH | Respiratory support system and patient set for this |
DE102017008791A1 (en) | 2017-09-20 | 2019-03-21 | Drägerwerk AG & Co. KGaA | Method of operating a ventilator and ventilator operating on the procedure |
EP3846889A4 (en) * | 2018-09-04 | 2022-06-01 | Fisher & Paykel Healthcare Limited | Support for a breathing assistance apparatus and/or accessories |
JP7290406B2 (en) * | 2018-10-03 | 2023-06-13 | 帝人ファーマ株式会社 | Breathing gas supply device and its control method |
CN110947062A (en) * | 2019-03-31 | 2020-04-03 | 湖南明康中锦医疗科技发展有限公司 | Respiration withdrawal judgment method of respiration support equipment |
DE102020002278A1 (en) * | 2019-04-24 | 2020-10-29 | Löwenstein Medical Technology S.A. | Breathing gas supply system and procedure |
CN112969486B (en) * | 2019-10-10 | 2023-02-28 | 深圳迈瑞生物医疗电子股份有限公司 | Ventilation switching control method and device, medical ventilation equipment and storage medium |
CN114126691B (en) * | 2019-12-03 | 2024-10-11 | 深圳迈瑞生物医疗电子股份有限公司 | Pressure generating device identification method and system, ventilation support device, and storage medium |
CN111298255B (en) * | 2020-02-22 | 2023-07-18 | 湖南城市学院 | Breathing machine based on ventilation capacity automatic triggering switching output respiratory air pressure |
DE102020202798A1 (en) * | 2020-03-05 | 2021-09-09 | Robert Bosch Gesellschaft mit beschränkter Haftung | Breathing gas analyzer and procedure for its operation |
CN111632241B (en) * | 2020-06-08 | 2021-05-11 | 山东科技大学 | Control system of humidification therapeutic instrument |
CN114681739B (en) * | 2020-12-30 | 2024-07-30 | 深圳迈瑞生物医疗电子股份有限公司 | Anesthesia breathing equipment and breathing circuit compliance detection method |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3834382A (en) | 1972-09-05 | 1974-09-10 | Johnson Service Co | Fluidic respirator control system with patient triggering response means |
US5632269A (en) * | 1989-09-22 | 1997-05-27 | Respironics Inc. | Breathing gas delivery method and apparatus |
DE4122069A1 (en) * | 1991-07-04 | 1993-01-07 | Draegerwerk Ag | METHOD FOR DETECTING A PATIENT'S BREATHING PHASES IN ASSISTANT VENTILATION METHODS |
DE4432219C1 (en) | 1994-09-10 | 1996-04-11 | Draegerwerk Ag | Automatic breathing system for patients |
US5551419A (en) * | 1994-12-15 | 1996-09-03 | Devilbiss Health Care, Inc. | Control for CPAP apparatus |
DE19528113C2 (en) * | 1995-08-01 | 2002-09-12 | Univ Ludwigs Albert | ventilator |
JP2926392B2 (en) * | 1996-06-03 | 1999-07-28 | レスピロニクス,インコーポレイテッド | Detector |
DE10031079A1 (en) * | 2000-06-30 | 2002-02-07 | Map Gmbh | Measuring patient breathing and state, correlates present respiration signals with prior reference measurements, to adjust CPAP therapy pressure accordingly |
US6439229B1 (en) | 2000-08-08 | 2002-08-27 | Newport Medical Instruments, Inc. | Pressure support ventilation control system and method |
DE102004014538A1 (en) * | 2004-03-23 | 2005-10-13 | Seleon Gmbh | Method for controlling a BiLevel device and BiLevel device |
WO2007059263A2 (en) * | 2005-11-16 | 2007-05-24 | Cardiopulmonary Technologies, Inc, | Side-stream respiratory gas monitoring system and method |
DE102007052897B4 (en) * | 2007-11-07 | 2013-02-21 | Dräger Medical GmbH | Method for automatically controlling a ventilation system and associated ventilation system |
WO2012024733A2 (en) * | 2010-08-27 | 2012-03-01 | Resmed Limited | Adaptive cycling for respiratory treatment apparatus |
CN103124574B (en) * | 2010-09-10 | 2016-06-08 | 皇家飞利浦电子股份有限公司 | System and method for identification of breathing conversion |
CN103608062B (en) * | 2011-03-18 | 2016-04-13 | 马奎特紧急护理公司 | Support breathing apparatus and the method for ventilation |
CN103182120B (en) * | 2011-12-30 | 2016-06-15 | 北京谊安医疗系统股份有限公司 | Invasive respirator is the device of man-machine synchronization under noninvasive ventilation mode |
-
2016
- 2016-04-15 DE DE102016206442.8A patent/DE102016206442A1/en not_active Withdrawn
-
2017
- 2017-04-10 US US16/093,818 patent/US20200215283A9/en not_active Abandoned
- 2017-04-10 AU AU2017251164A patent/AU2017251164A1/en not_active Abandoned
- 2017-04-10 JP JP2018550597A patent/JP2019511301A/en not_active Ceased
- 2017-04-10 CN CN201780023459.5A patent/CN109069780A/en active Pending
- 2017-04-10 EP EP17716248.4A patent/EP3247437B1/en active Active
- 2017-04-10 WO PCT/EP2017/058577 patent/WO2017178440A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CN109069780A (en) | 2018-12-21 |
AU2017251164A1 (en) | 2018-09-13 |
US20200215283A9 (en) | 2020-07-09 |
WO2017178440A1 (en) | 2017-10-19 |
DE102016206442A1 (en) | 2017-10-19 |
US20190134331A1 (en) | 2019-05-09 |
JP2019511301A (en) | 2019-04-25 |
EP3247437B1 (en) | 2018-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3247437B1 (en) | Respirator having improved synchronicity during the transition from expiratory to inspiratory operation | |
DE102006030520B3 (en) | Respiratory gas supplying device for patient, has control device that is provided for controlling inspiration pressure based on pulmonary inner pressure and pulmonary target pressure | |
EP1960025B1 (en) | Flexible conduit system for respiratory devices | |
DE60224964T2 (en) | Respiratory equipment for use in examining the respiratory mechanics of a respiratory system | |
DE102004006396B4 (en) | Device for ventilation and method for controlling a ventilator | |
EP0491969B1 (en) | Lung ventilator with a flow rate dependent trigger threshold | |
DE10217762C1 (en) | Respiration gas supply control method for artificial respirator compares actual respiration path pressure with intial respiration path pressure for regulation of respiration gas supply parameter | |
EP3691723B1 (en) | Ventilator with automatic detection of a fault in a flow sensor, taking into account spontaneous breathing | |
WO2010136923A1 (en) | Ventilator and adjustment method therefor | |
EP3344317A1 (en) | Ventilator with error detection for flow sensors | |
DE102017217859A1 (en) | Ventilation device with flow and pressure signal based detection of errors of a flow sensor of the device | |
DE102017008791A1 (en) | Method of operating a ventilator and ventilator operating on the procedure | |
EP3261698B1 (en) | Respiratory device | |
DE102007054390A1 (en) | Rebreathing gas portion determining method for use in respiration gas supply system, involves determining expiration and leakage volumes, and determining difference between expiration and leakage volumes as rebreathing portion | |
EP1586343B1 (en) | Breathing device and method of controlling a breathing device | |
EP4141846A1 (en) | System for simulating the breathing of a living being | |
DE602004003409T2 (en) | Device for the determination of suction flow and suction time and for the extraction of dead space | |
EP3957347B1 (en) | Ventilator for high-flow oxygen therapy | |
DE102020123138B3 (en) | Method and device for the automatic determination of the setpoint frequency of a ventilator | |
WO2021083981A1 (en) | Method for carrying out a p/v maneuver which automatically prevents an over-dilation of the lungs, and ventilation device designed to carry out the method | |
WO2022111848A1 (en) | Detection of asynchrony during respiratory treatment | |
DE102022108124A1 (en) | Ventilation device and method with spontaneous breathing phases | |
DE102006018042A1 (en) | Respirator controlling method for use by e.g. ill patient, involves carrying out measurements and data storages by controlling respirator in functional condition, where respirator automatically selects conditions due to measurements | |
EP4079358A1 (en) | Ventilation apparatus for mechanical ventilation of a patient | |
EP3097938A1 (en) | Device for applying a medical gas to a patient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20170720 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20180601 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: NOVOTNI, DOMINIK Inventor name: MEYER, JOHANNES BJOERN THOMAS |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1058647 Country of ref document: AT Kind code of ref document: T Effective date: 20181115 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502017000308 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: E. BLUM AND CO. AG PATENT- UND MARKENANWAELTE , CH |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: NO Ref legal event code: T2 Effective date: 20181031 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190228 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190131 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190201 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190301 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502017000308 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20190801 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20190430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190410 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20170410 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NO Payment date: 20230322 Year of fee payment: 7 Ref country code: IE Payment date: 20230322 Year of fee payment: 7 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230521 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20230321 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20230502 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20230322 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240320 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20240320 Year of fee payment: 8 Ref country code: FR Payment date: 20240320 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240320 Year of fee payment: 8 |